Crossref journal-article
Wiley
Cancer Science (311)
Abstract

Alternative polyadenylation (APA), which induces shortening of the 3′UTR, is emerging as an important phenomenon in gene regulation. APA is involved in development, cancer and cell proliferation. APA may lead to disruption of microRNA‐mediated gene silencing in cancer cells via detachment of microRNA binding sites. We studied the correlation between the APA profile and the tumor aggressiveness in cases of lung cancer. We selected the top 10 genes showing significant 3′UTR shortening in lung cancer, using the package of the Bioconductor for probe‐level analyses of expression microarrays. We established and evaluated the APA score by quantitative RT‐PCR in 147 clinical specimens of non‐small cell lung cancer and compared the results with the clinical outcomes and expression levels of APA‐related genes, including PABPN1, CPEB1, E2F1 and proliferation markers (MKI67, TOP2A and MCM2). High APA scores were correlated with an advanced tumor stage and a poor prognosis (P < 0.001). Multivariate analysis identified the APA score as an independent prognostic factor (hazard ratio, 3.0; P = 0.03). Both lower expression of PABPN1 and higher expression of the proliferation markers were correlated with high APA scores and a poor prognosis, with suppression of PABPN1 exerting its influence independent of gain of the proliferation markers. Moreover, the APA score was correlated with the maximum standardized uptake value of the tumors on positron emission tomography (r = 0.53; P < 0.001). Our results indicate that the loss of PABPN1, a suppressor of APA, might promote tumor aggressiveness by releasing the cancer cells from microRNA‐mediated gene regulation.

Bibliography

Ichinose, J., Watanabe, K., Sano, A., Nagase, T., Nakajima, J., Fukayama, M., Yatomi, Y., Ohishi, N., & Takai, D. (2014). Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non‐small cell lung cancer. Cancer Science, 105(9), 1135–1141. Portico.

Authors 9
  1. Junji Ichinose (first)
  2. Kousuke Watanabe (additional)
  3. Atsushi Sano (additional)
  4. Takahide Nagase (additional)
  5. Jun Nakajima (additional)
  6. Masashi Fukayama (additional)
  7. Yutaka Yatomi (additional)
  8. Nobuya Ohishi (additional)
  9. Daiya Takai (additional)
References 38 Referenced 34
  1. 10.1016/j.cell.2009.01.002
  2. 10.1073/pnas.242606799
  3. 10.1158/0008-5472.CAN-04-0637
  4. 10.1158/0008-5472.CAN-05-2352
  5. 10.1016/j.ccr.2006.01.025
  6. 10.3389/fgene.2013.00275
  7. 10.1056/NEJMoa0803785
  8. 10.1101/gad.1848209
  9. 10.1016/j.cell.2010.05.017
  10. 10.1038/ng.317
  11. 10.1111/j.1349-7006.2005.00015.x
  12. 10.1111/j.1349-7006.2011.02101.x
  13. 10.1002/ijc.26254
  14. 10.1093/nar/gki158
  15. 10.1016/j.cell.2010.11.020
  16. 10.1261/rna.2581711
  17. 10.1126/science.1111443
  18. 10.1126/science.1155390
  19. 10.1073/pnas.0900028106
  20. 10.1242/dev.047324
  21. 10.1371/journal.pone.0008419
  22. 10.1016/j.cell.2009.06.016
  23. 10.1101/gr.115295.110
  24. 10.1186/gb-2012-13-7-r59
  25. 10.1038/nature11901
  26. 10.1016/j.cell.2012.03.022
  27. 10.3109/10520299709082216
  28. 10.1016/j.bbrc.2005.03.224
  29. 10.1038/sj.bjc.6604967
  30. {'key': 'e_1_2_7_31_1', 'first-page': '351', 'article-title': 'MCM proteins as diagnostic and prognostic tumor markers in the clinical setting', 'volume': '25', 'author': 'Giaginis C', 'year': '2010', 'journal-title': 'Histol Histopathol'} / Histol Histopathol / MCM proteins as diagnostic and prognostic tumor markers in the clinical setting by Giaginis C (2010)
  31. 10.1016/j.lungcan.2012.10.008
  32. {'volume-title': 'International Union Against Cancer (UICC) TNM Classification of Malignant Tumours', 'year': '2010', 'author': 'Sobin LH', 'key': 'e_1_2_7_33_1'} / International Union Against Cancer (UICC) TNM Classification of Malignant Tumours by Sobin LH (2010)
  33. 10.1371/journal.pone.0007479
  34. 10.1016/j.lungcan.2008.03.033
  35. 10.1016/j.bbrc.2011.12.068
  36. 10.1371/journal.pone.0031129
  37. 10.1158/1078-0432.CCR-12-0543
  38. 10.1158/0008-5472.CAN-09-2236
Dates
Type When
Created 11 years, 2 months ago (June 28, 2014, 5:45 a.m.)
Deposited 1 year, 11 months ago (Oct. 2, 2023, 10:22 p.m.)
Indexed 4 months, 2 weeks ago (April 17, 2025, 8:04 a.m.)
Issued 11 years ago (Sept. 1, 2014)
Published 11 years ago (Sept. 1, 2014)
Published Online 11 years ago (Sept. 3, 2014)
Published Print 11 years ago (Sept. 1, 2014)
Funders 7
  1. JSPS KAKENHI
    Awards1
    1. 23390147
  2. JSPS KAKENHI
    Awards1
    1. 24659267
  3. JSPS KAKENHI
    Awards1
    1. 25830098
  4. JSPS KAKENHI
    Awards1
    1. 24791455
  5. JSPS KAKENHI
    Awards1
    1. 23249045
  6. JSPS KAKENHI
    Awards1
    1. 22249017
  7. Takeda Science Foundation 10.13039/100007449

    Region: Asia

    gov (Trusts, charities, foundations (both public and private))

    Labels2
    1. 公益財団法人 武田科学振興財団
    2. TSF

@article{Ichinose_2014, title={Alternative polyadenylation is associated with lower expression of <scp>PABPN</scp>1 and poor prognosis in non‐small cell lung cancer}, volume={105}, ISSN={1349-7006}, url={http://dx.doi.org/10.1111/cas.12472}, DOI={10.1111/cas.12472}, number={9}, journal={Cancer Science}, publisher={Wiley}, author={Ichinose, Junji and Watanabe, Kousuke and Sano, Atsushi and Nagase, Takahide and Nakajima, Jun and Fukayama, Masashi and Yatomi, Yutaka and Ohishi, Nobuya and Takai, Daiya}, year={2014}, month=sep, pages={1135–1141} }